Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Microchip Technology Incorporated disclosed that its Data Center Solutions Business Unit generated $302.7 million in revenue in 2025 and anticipates approximately 65% growth to about $500 million in 2026. This accelerated growth underscores Microchip's expanding presence in data center components, including storage controllers, PCIe and CXL memory …
Microchip Technology Incorporated announced the appointment of Mitch Little, former senior executive at Microchip, to its Board of Directors effective June 1, 2026. Little brings extensive experience in sales, product management, and leadership, and meets Nasdaq's independence requirements. The company highlighted his role in shaping Microchip's cu…
JM Group Limited, a Hong Kong-based sourcing and wholesale solutions provider, provided an update concerning the ongoing trading halt on its securities by the NYSE. The company disclosed that its special committee, with assistance from outside counsel, is conducting an internal investigation related to the halt. It has responded to all inquiries an…
Praxis Precision Medicines announced that the Phase 2/3 POWER1 study of vormatrigine in patients with focal onset seizures did not meet its primary endpoint of seizure frequency reduction, though a secondary measure of 50% response rate was met and higher dose showed more pronounced seizure reduction. Vormatrigine was generally well-tolerated with …
The XAI Octagon Floating Rate & Alternative Income Trust announced its monthly common share distribution of $0.225 per share, unchanged from the previous month. The distribution is payable on July 1, 2026, to shareholders of record as of June 15, 2026. The Trust invests primarily in floating rate credit instruments and structured credit investments…
Fulcrum Therapeutics Inc. (NASDAQ:FULC) said it will stop development of pociredir for sickle cell disease after the FDA expressed concerns about malignancy risks linked to drugs that target the PRC2 complex. The announcement prompted a roughly 30% drop in the stock in after-hours trading. The company has opened a strategic review and is cutting co…
Hewlett Packard Enterprise delivered a record second quarter driven by heavy demand for servers and networking equipment tied to AI workloads. The company raised its fiscal 2026 revenue and earnings outlook and said the revised targets exceed its prior 2028 projections, citing enterprise adoption of agentic AI and continued infrastructure moderniza…
Director Michael C. Turmelle recently increased his direct stake in Ideal Power Inc. (NASDAQ:IPWR) by acquiring 5,250 common shares. This activity occurs against a backdrop of the company completing a registered direct offering that raised $30 million. The proceeds are earmarked for advancing the commercialization efforts of its B-TRAN bidirectiona…
Golconda Gold has begun mining at Princeton Top and is feeding ore to the plant, a tangible execution milestone. With price around $1.89, constructive moving averages, neutral RSI and a bullish MACD histogram, the setup offers a measured long trade: entry $1.89, stop $1.60, target $2.40 over the next 45 trading days.
The Chief Executive Officer of CuriosityStream Inc., Clinton Larry Stinchcomb, recently purchased a notable amount of the company's common stock. This transaction occurs amidst varying market signals for CuriosityStream (NASDAQ: CURI), including recent reported revenue figures that fell below expectations and strategic announcements regarding conte…
Director David Henry Hoffmann, a ten percent owner of Lee Enterprises (LEE), recently executed several transactions acquiring significant quantities of the company's common stock. These purchases occur against a backdrop of positive corporate developments for LEE, including strong second-quarter financial results and a new management agreement with…
Executive Vice President and Chief Commercial Officer Alberto Uggetti recently sold shares of UL Solutions Class A Common Stock under a pre-arranged trading plan. This transaction occurred against a backdrop of positive corporate news, including strong first quarter 2026 financial results, an announced quarterly dividend, and the launch of new AI p…
UroGen Pharma Ltd., a biotech company focused on urothelial and specialty cancers, announced its management will present at the Goldman Sachs 47th Annual Global Healthcare Conference in June 2026. The presentation will include a fireside chat and investor meetings, with a webcast available on UroGen's website.
Abivax reported positive Phase 3 ABTECT maintenance trial results for obefazimod, an oral miR-124 enhancer, showing significant clinical remission rates at week 44 in patients with moderately to severely active ulcerative colitis. Both 25 mg and 50 mg doses met primary and all key secondary endpoints with a favorable safety profile. The company pla…
Heidmar Maritime Holdings Corp. disclosed the departure of CFO Niki Fotiou effective May 31, 2026, and initiated a search for her successor. CEO Pankaj Khanna will manage the finance function during the transition to ensure business continuity and no disruption is expected in financial reporting or operations.
Fulcrum Therapeutics announced discontinuation of its pociredir program for sickle cell disease after receiving FDA feedback that raised concerns about the risk of secondary malignancies linked to the drug's target, influenced by a related drug's market withdrawal. Despite positive clinical signals, the FDA sees no viable regulatory path forward. F…
Pulmonx Corporation announced equity awards in the form of restricted stock units to 17 new employees as inducements to join the company in early 2026, following their 2025 Inducement Plan in compliance with Nasdaq Listing Rule 5635(c)(4). The awards include 84,300 RSUs with scheduled vesting over four years. Pulmonx is a market leader in minimally…
Epsilon Energy Ltd. announced a quarterly dividend of $0.0625 per share payable June 30, 2026, and a borrowing base redetermination increasing the credit facility commitments to $90 million, with $40.5 million currently outstanding. The company operates across multiple North American natural gas and oil basins.
Resmed has completed its acquisition of Noctrix Health, integrating the latter's FDA-approved, non-pharmacologic wearable therapy for Restless Legs Syndrome (RLS). This move broadens Resmed's product offerings in clinical sleep health and aims to enhance patient access and outcomes through connected health technologies.
Dave & Buster's Entertainment, Inc. will report its financial results for the first quarter ending May 5, 2026, on June 15, 2026 after market close. Management will host a conference call to discuss the results, providing insights into the company's ongoing operations and performance of its entertainment and dining venues.
Merlin, Inc., an aerospace and defense technology company focused on autonomous flight systems, has announced its management will take part in multiple investor conferences throughout June 2026. The events include the Jefferies Defense Tech Summit, ROTH Capital Partners Annual London Conference, and the Maxim Group Defense Tech Conference. The comp…
Broadcom Inc. announced a comprehensive suite of broadband Edge AI products, including a 50G PON gateway SoC, Wi-Fi 8 product family, and a joint 5G/Wi-Fi 8 fixed wireless access platform. These innovations are designed to support next-generation AI-driven applications by delivering ultra-low latency, enhanced security, and intelligent localized pr…
Minerva Neurosciences has established a Scientific Advisory Board (SAB) composed of leading experts in psychiatry and neuroscience to guide the clinical development of roluperidone, an investigational drug targeting negative symptoms of schizophrenia, and to advise on future pipeline programs. The SAB formation fulfills a prior PIPE financing commi…
A regulatory filing dated Monday shows SpaceX will reserve 5% of the shares in its planned initial public offering for certain employees and individuals chosen by executive officers, offering those shares at the IPO price through a directed share program and exempting them from typical post-IPO lock-up restrictions. The filing does not disclose the…
Keros Therapeutics announced that its President and CEO Jasbir S. Seehra, Ph.D., will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026. The live webcast and replay will be available to investors. Keros is a clinical-stage biopharmaceutical company developing novel therapeutics targeting th…
